Investors in Marinus Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights - MRNSAccesswire • 07/29/24
DEADLINE NEXT WEEK: Berger Montague Advises Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Investors to Contact the Firm Before August 5, 2024GlobeNewsWire • 07/29/24
Marinus Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights - MRNSAccesswire • 07/28/24
Lost Money on Marinus Pharmaceuticals, Inc.(MRNS)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyAccesswire • 07/28/24
Marinus Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 MRNSAccesswire • 07/28/24
MRNS Deadline: MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud LawsuitPRNewsWire • 07/27/24
Marinus Pharmaceuticals Inc Is Being Probed By The Schall Law Firm Which Motivates Affected Investors To Begin DiscussionsAccesswire • 07/26/24
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit - MRNSPRNewsWire • 07/26/24
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 07/25/24
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MarinusPRNewsWire • 07/25/24
The Gross Law Firm Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRNSPRNewsWire • 07/25/24
Levi & Korsinsky Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNSAccesswire • 07/24/24
Investors who lost money on Marinus Pharmaceuticals, Inc.(MRNS) should contact Levi & Korsinsky about pending Class Action - MRNSAccesswire • 07/24/24
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Lawsuit Filed by the Schall Law FirmPRNewsWire • 07/24/24
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) ShareholdersAccesswire • 07/24/24
Levi & Korsinsky Reminds Marinus Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNSAccesswire • 07/23/24
UPCOMING MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!Accesswire • 07/23/24
Shareholders of Marinus Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights – MRNSAccesswire • 07/22/24
Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) should contact The Gross Law Firm about pending Class Action - MRNSGlobeNewsWire • 07/22/24
Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) - August 5, 2024 Deadline to Join - Contact Levi & KorsinskyAccesswire • 07/21/24
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNSGlobeNewsWire • 07/20/24
Contact Levi & Korsinsky by August 5, 2024 Deadline to Join Class Action Against Marinus Pharmaceuticals, Inc. (MRNS)Accesswire • 07/19/24
Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on August 5, 2024 in Marinus LawsuitPRNewsWire • 07/19/24
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit Filed by The Rosen Law FirmPRNewsWire • 07/19/24
Marinus Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm Which Urges Impacted Investors To Initiate ConversationsAccesswire • 07/18/24
